Acrongenomics Acquires Equity Stake in Molecular Vision
Geneva (ots/PRNewswire) - Acrongenomics, Inc. (OTC: AGNM) is pleased to announce that they have acquired a 10.9% interest in Molecular Vision Limited, on a fully diluted basis. The cash consideration will be used by Molecular Vision for working capital and to further develop its technology. Molecular Vision is developing low cost easy-to-use credit-card sized devices for medical testing that will greatly extend ...